Optimizing ventricular tachycardia ablation through imaging-based assessment of arrhythmic substrate: A comprehensive review and roadmap for the future.

Janneke C Burger¹, Luuk H G A Hopman¹, Michiel J B Kemme¹, Wiert Hoeksema¹, Richard A P Takx², Rosa M Figueras I Ventura³, Fernando O Campos⁴, Gernot Plank⁵, R Nils Planken², Cornelis P Allaart¹, Vokko P van Halm¹, Pieter G Postema¹, Marco J W Götte¹, Martin J Bishop⁴, Pranav Bhagirath^1,4

¹Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

²Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.

³Adas3D Medical S.L., Barcelona, Spain.

⁴School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

⁵Gottfried Schatz Research Center, Division of Biophysics, Medical University of Graz, Graz, Austria.

PubMed PMC DOI PDF

Abstract

Ventricular tachycardia (VT) is a life-threatening heart rhythm and has long posed a complex challenge in the field of cardiology. Recent developments in advanced imaging modalities have aimed to improve comprehension of underlying arrhythmic substrate for VT. To this extent, high-resolution cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) have emerged as tools for accurately…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.